The Evolving Pharma R&D Outsourcing Industry: A Bird's-eye View

Sean Preci
Published on
February 10, 2020

Pharmaceutical companies are increasingly outsourcing their R&D activities, including early-stage research programs, to third party organizations – academic institutions, biotech startups, and private contract research organizations (CROs) – as a means to stay competitive, flexible, and profitable against all odds.

Take the Next Step

1
2
3

Explore Suppliers

Browse trusted partners with relevant expertise

Review Capabilities

Compare services, experience, and past work

Start Your Project

Connect and begin collaborating

Written by
Sean Preci
Share this post

Read Futher

Read Further